Lentiviral vector transduced CD34+ cells Therapy |
|
临床二期 |
Great Ormond Street Hospital For Children Nhs Foundation Trust |
慢性肉芽肿病 |
详情
|
Autologous peripheral blood stem cell therapy (CellProthera) |
|
临床二期 |
Cellprothera |
心肌梗塞 |
详情
|
Stem cell therapeutics (ExCellThera) |
ECT-002; ECT-003; ECT-005; UM171 + UM092; UM171 + UM390 |
临床二期 |
Excellthera Inc |
血液肿瘤, 多发性骨髓瘤, 急性髓细胞样白血病 |
详情
|
Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene (Orchard) |
OTL-201 |
临床二期 |
The University Of Manchester |
Ⅲ型黏多糖贮积症 |
详情
|
shRNA-Modified CD34 Cell Therapy |
|
临床一期 |
康霖生物科技(杭州)有限公司 |
HIV感染 |
详情
|
Retroviral ADA-transduced CD34+ cells (NHGRI/UCLA) |
|
临床二期 |
Ucla Biomedical Library |
腺苷脱氨酶缺乏 |
详情
|
CD34+ bone marrow stem cells (University of California) |
|
临床二期 |
加利福尼亚大学戴维斯分校 |
色素性视网膜炎, 糖尿病视网膜病变, 年龄相关性黄斑变性, 视网膜静脉阻塞 |
详情
|
CLBS-12 |
CLBS-12 |
临床二期 |
Caladrius Biosciences Inc |
动脉粥样硬化, 闭塞性血栓性脉管炎, 缺血 |
详情
|
GSK-2696277 |
GSK-2696277; OTL-300 |
临床二期 |
葛兰素史克, Ospedale San Raffaele, Fondazione Telethon |
β-地中海贫血 |
详情
|
Autologous CD34+-enriched hematopoietic stem and progenitor cells (Genenta Science) |
|
临床二期 |
Genenta Science Srl |
胶质母细胞瘤, 多发性骨髓瘤 |
详情
|
Alpha-galactosidase A stem cell therapy (University Health Network/Ozmosis) |
|
临床一期 |
University Health Network |
法布里病 |
详情
|
Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion(German Cancer Research Center) |
|
临床一期 |
German Cancer Research Center (Dkfz) |
急性髓细胞样白血病 |
详情
|
Cord blood stem cells(Tatcitus Therapeutics/Mount Sinai Health System) |
HSC-100 |
临床一期 |
Icahn School Of Medicine At Mount Sinai, Tatcitus Therapeutics |
白血病, 血液肿瘤, 霍奇金病, 骨髓增生异常综合征, 急性淋巴细胞白血病, 非霍奇金淋巴瘤 |
详情
|